Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00467558 · ClinicalTrials.gov registry record · Phase 2
Double-Blind Naltrexone in Compulsive Sexual Behavior
A Phase 2 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 2
- Development phase
- 7
- Enrollment target
NCT00467558 is a Phase 2 study that has completed, run by University of Minnesota. The registered enrollment target is 7 participants.
The verdict
NCT00467558, a Phase 2 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 7 participants
- Enrollment target
Study Summary
The goal of the proposed study is to evaluate the efficacy and safety of naltrexone in compulsive sexual behavior. Twenty subjects with DSM-IV compulsive sexual behavior will receive 8 weeks of naltrexone or placebo. The hypothesis to be tested is that naltrexone will be effective in reducing the urges to act out sexually in patients with compulsive sexual behavior. The proposed study will provide needed data on the treatment of a disabling disorder that currently lacks a clearly effective treatment.
Interventions
- DRUG Naltrexone
- DRUG Sugar pill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2007-05 |
| Est. Completion | 2010-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00467558
The ClinicalTrials.gov registry entry for NCT00467558 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Naltrexone is the first listed.
NCT00467558 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00467558 about?
NCT00467558 is a clinical study titled "Double-Blind Naltrexone in Compulsive Sexual Behavior". The goal of the proposed study is to evaluate the efficacy and safety of naltrexone in compulsive sexual behavior. Twenty subjects with DSM-IV compulsive sexual behavior will receive 8 weeks of naltrexone or placebo. The hypothesis to be tested is that naltrexone will be effective in reducing the ur...
What is the current status of trial NCT00467558?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 7 participants. The study started on 2007-05. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00467558?
The interventions under investigation include: Naltrexone (DRUG), Sugar pill (DRUG).
Who is sponsoring clinical trial NCT00467558?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.